Delivery Order SPE2DB22D9304-SPE2DB25FSSV8
Award Date
6/3/25
Potential Completion Date
6/25/25
Potential Value
$16K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of STELARA 90 MG/ML SYRINGE to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract has a ceiling value of $16,441.36 and is a firm fixed-price delivery order with a completion date of June 10, 2025. DMS Pharmaceutical Group Inc. is an experienced federal contractor, holding a significant single-award Indefinite...
This federal contract award is for the delivery of STELARA 90 MG/ML SYRINGE pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The contract has a ceiling value of $97,499.70 and is a firm fixed-price delivery order contract valid through June 20, 2025. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $16,249.95 firm fixed-price delivery order is for the supply of STELARA 90 MG/ML SYRINGEML, with a completion date of June 12, 2025. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue delivery orders for a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of Stelara 90 mg/ml syringes, with a ceiling value of $16,249.95 and a period of performance through June 17, 2025. DMS Pharmaceutical Group Inc. is an established federal contractor, holding a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program to...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of STELARA 90 MG/ML SYRINGEML, a pharmaceutical product, with a ceiling value of $16,249.95 and a completion date of June 9, 2025. DMS Pharmaceutical Group holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999...
This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order valued at $24,662.04 for the supply of Stelara 90 mg/ml syringes. The contract has an ultimate completion date of April 29, 2025 and is not associated with any set-aside designation. DMS Pharmaceutical Group Inc. holds a significant single-award...
This is a federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and is a delivery order valued at $8,220.68. The contract is for the supply of STELARA 90 MG/ML SYRINGEML, a pharmaceutical product, and has a firm fixed-price pricing type. The contract has an ultimate completion date of May 2, 2025 and was awarded on April 11,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $16,249.95 contract is for the supply of Stelara 90 mg/ml syringes, with a period of performance through June 20, 2025. DMS Pharmaceutical Group holds a significant Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November...
This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $16,249.95 firm fixed-price delivery order is for the supply of STELARA 90 MG/ML SYRINGE syringes, with a period of performance through June 25, 2025. The contract does not have a set-aside designation. DMS Pharmaceutical Group holds a single-award Indefinite Delivery Contract (IDC) with the DLA...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $7,212.00, is for the delivery of STELARA (ustekinumab) 130 mg/26 ml vials to support the recurring pharmaceutical needs of military health facilities. This delivery order is placed under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the...